查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1933890

全球醫藥級水市場（按產品類型、生產流程、最終用戶和應用分類）預測（2026-2032）

Pharmaceutical Grade Water Market by Product Type, Manufacturing Process, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫藥級水市場價值將達到 48.9 億美元，到 2026 年將成長至 52.2 億美元，到 2032 年將達到 81.2 億美元，年複合成長率為 7.51%。

關鍵市場統計數據
基準年 2025 48.9億美元
預計年份：2026年 52.2億美元
預測年份 2032 81.2億美元
複合年成長率 (%) 7.51%

在日益成長的技術和監管壓力下，了解高純度水在現代製藥生產和臨床環境中的關鍵作用

藥用級水處於監管審查、生產可靠性和病人安全三者交匯點，是眾多治療和臨床流程中不可或缺的基礎組成部分。膜技術的最新進展、生物製藥生產日益複雜的過程以及臨床環境中不斷強化的衛生通訊協定，都提升了水系統運作的重要性，並迫使各機構重新思考其設計、驗證和維護模式。

技術創新、更嚴格的監管和不斷發展的生產方法如何融合，將重新定義製藥用水系統的戰略重點

製藥級水產業正經歷著變革性的轉變，其驅動力包括技術的整合、日益嚴格的監管以及製造地的轉變。逆滲透和超過濾等膜技術正與先進的監測和自動化工具相結合，以實現即時品質保證和預測性維護，從而減少非計劃性停機時間。同時，製程團隊正在重新評估傳統的蒸餾系統，轉而採用兼顧穩健性和能源效率的混合解決方案。

評估2025年關稅調整對製藥用水處理設備及零件供應鏈的多面向營運與採購影響

2025年關稅調整對水處理系統採購、資本設備購買和零件採購都產生了實際的影響。部分進口零件關稅的提高促使工程團隊重新評估供應商選擇策略，並加快關鍵零件的在地採購，以確保進度和成本的可預測性。一些製造商已修訂採購計劃並調整材料清單（BOM），以降低關稅波動帶來的風險。

揭示水處理系統在產品類型、最終用戶、應用和製造流程等方面的細微細分動態，從而推動技術和商業性差異化。

細分市場分析揭示了技術、使用者、應用和製程領域中不同的細分市場，這些細分市場影響著產品選擇、檢驗複雜性和生命週期成本。依產品類型分類，市場分析涵蓋純淨水、注射無菌水、血液透析用水和注射用水。純淨水再細分為去離子、蒸餾、逆滲透和超過濾。蒸餾技術本身分析了其間歇式和連續式兩種變體，而逆滲透則分析了中空纖維和螺旋型。注射用水進一步細分為蒸餾技術和薄膜技術，其中薄膜技術透過超過濾進行探討。

美洲、歐洲、中東和非洲以及亞太地區的區域戰略差異和營運重點將影響製藥用水解決方案的採用和部署。

區域趨勢要求在實施、合規和供應商合作方面採取差異化的方法。美洲地區正集中投資於現有設施的現代化改造和數位化監控，因為監管要求和大規模生物製藥製造地推動了嚴格的驗證框架和高運轉率標準的製定。該地區的投資趨勢傾向於優先考慮遠端監控和預測性維護的整合，以保障連續生產線和高價值藥物的生產。

競爭格局分析揭示了產品整合、服務品質和數位化準備如何使領先的水系統供應商與利基市場和新興企業區分開來。

主要企業的發展趨勢表明，競爭格局由產品線的廣度、監管專業知識、服務網路和工程能力共同塑造。領先的系統供應商透過提供集水生產、分配、監控和全生命週期支援於一體的整合解決方案脫穎而出，幫助客戶加快驗證速度並降低整體擁有成本。擁有強大的全球服務網路和區域技術團隊的公司，能夠透過統一的合格文件和快速的現場回應，更好地為跨國客戶提供支援。

為製造商和供應商提供一條切實可行的途徑，以加快水系統檢驗和運作，同時增強合規性、韌性和成本控制。

產業領導者應優先採取一系列策略行動，在合規性、韌性和成本效益之間取得平衡，以應對不斷變化的環境。首先，採用模組化系統結構和檢驗的替代籌資策略，以維持驗證的連續性，同時降低供應鏈中斷和關稅帶來的成本壓力。其次，投資於自動化監控、資料完整性框架和預測性維護計劃，以提高運作並滿足生命週期品質預期，同時避免過多的人工干預。

採用穩健的混合方法研究途徑，結合從業人員訪談、規範分析和資料三角驗證，以檢驗有關製藥用水系統的研究結果。

本研究採用多層次調查方法，結合了業界從業人員的初步研究及技術標準、法規指南及同儕審查文獻的二次蒐集。初步研究包括對製程工程師、品質保證人員、採購經理和外部驗證專家進行結構化訪談，並輔以對水生產和分配系統的現場觀察，以了解運作限制。二次研究則利用法規文件、標準機構指南、技術白皮書和已發表的案例研究，為技術選擇和合規性解讀提供背景資訊。

整合策略和營運重點，揭示技術選擇和組織協調如何決定製藥用水系統專案的成功。

總之，對於尋求滿足日益成長的品質要求和營運需求的製造商和臨床試驗機構而言，藥用級水既是技術基礎，也是戰略槓桿。從去離子和逆滲透配置到蒸餾結構和超過濾濾膜，技術選擇直接影響驗證的複雜性、維護方案和能耗情況。同時，最終使用者的特性決定了可接受的冗餘度、文件記錄和服務需求。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的藥用級水市場

  • 純淨水
    • 去離子
    • 蒸餾
      • 間歇蒸餾
      • 連續蒸餾
    • 逆滲透
      • 中空纖維膜
      • 螺旋纏繞式
    • 超過濾
  • 注射用無菌水
  • 血液透析用水
  • 注射用水
    • 蒸餾
    • 膜技術

9. 按生產流程分類的藥用級水市場

  • 去離子
  • 蒸餾
    • 間歇蒸餾
    • 連續蒸餾
  • 逆滲透
    • 高壓
    • 低壓
  • 超過濾

第10章：依最終用戶分類的醫藥級水市場

  • 合約研究機構
  • 醫院和診所
  • 製藥生產
    • 生技公司
    • 學名藥生產商
    • 大型製藥企業

第11章 按應用領域分類的醫藥級水市場

  • 設備清潔
  • 僅供實驗室使用
  • 注射液
    • 靜脈輸液
      • 大容量配方
      • 小容量輸液
    • 清潔液
  • 無菌包裝

第12章：各地區醫藥級水市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 醫藥級水市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國醫藥級水市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國藥用級水市場

第16章：中國醫藥級水市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aquafilsep
  • Aquatech International LLC
  • AQUAVISTA
  • Aqua-Chem, Inc.
  • Asahi Kasei Corporation
  • AWS Bio Pharma Technologies
  • Biocell Pharma
  • Biopuremax
  • BWT Group
  • CHIWATEC
  • Ecolab Inc.
  • Evoqua Water Technologies LLC
  • Fabtech
  • GEA Group Aktiengesellschaft
  • GT Metal & Process
  • Hydropure Systems
  • Kurita Water Industries Ltd.
  • LIVAM
  • MECO
  • Meissner Filtration Products, Inc.
  • Paragon Pharmaceutical Equipment Co., Ltd.
  • Parker Hannifin Corporation
  • Pharmalab India
  • Pure Aqua, Inc.
  • SUEZ SA
  • SUNCOMBE Ltd.
  • Tianjin Chaotuo Medical Equipment
  • Veolia Environnement SA
  • WEMAC Pharma Systems
  • Xylem Inc.
Product Code: MRR-C36616F699A8

The Pharmaceutical Grade Water Market was valued at USD 4.89 billion in 2025 and is projected to grow to USD 5.22 billion in 2026, with a CAGR of 7.51%, reaching USD 8.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.89 billion
Estimated Year [2026] USD 5.22 billion
Forecast Year [2032] USD 8.12 billion
CAGR (%) 7.51%

Framing the critical role of high-purity water in modern pharmaceutical operations and clinical environments amid evolving technical and regulatory pressures

Pharmaceutical grade water sits at the intersection of regulatory scrutiny, manufacturing reliability, and patient safety, making it a foundational input for a wide range of therapeutic and clinical processes. Recent advances in membrane technologies, growing complexity of biologics manufacturing, and heightened sanitation protocols across clinical settings have all elevated the operational importance of water systems, driving facilities to reassess design, validation, and maintenance paradigms.

Consequently, stakeholders across the value chain-from process engineers and quality assurance leads to procurement and clinical operations-must navigate evolving compliance expectations while optimizing for uptime and cost efficiency. This introduction establishes the imperatives that underpin subsequent sections: regulatory convergence, technology adoption, supply chain friction, and the strategic choices organizations face when designing or upgrading water systems for pharmaceutical and clinical applications.

How converging technological advances, regulatory tightening, and evolving manufacturing modalities are redefining strategic priorities for pharmaceutical water systems

The landscape for pharmaceutical grade water is undergoing transformative shifts driven by technology convergence, regulatory tightening, and shifting manufacturing footprints. Membrane technologies such as reverse osmosis and ultrafiltration are being integrated with advanced monitoring and automation tools, enabling real-time quality assurance and predictive maintenance that reduce unplanned downtime. Simultaneously, process teams are reevaluating legacy distillation systems in favor of hybrid solutions that balance robustness with energy efficiency.

These technological movements are accompanied by regulatory and GMP interpretive changes that emphasize lifecycle quality management and data integrity for water distribution and production systems. As organizations pursue biologics, personalized medicine, and higher-mix manufacturing, water systems must adapt to broader contamination risk profiles, necessitating investments in validation protocols, sensor networks, and trained personnel. Taken together, these forces are reshaping capital planning, supplier relationships, and operational frameworks across the industry.

Assessing the multifaceted operational and sourcing consequences of 2025 tariff adjustments on pharmaceutical water treatment equipment and component supply chains

Tariff changes implemented in 2025 have created tangible effects across procurement, capital equipment acquisition, and component sourcing for water treatment systems. Increased duties on specific imported components have prompted engineering teams to re-evaluate supplier qualification strategies and accelerate localization of critical elements to preserve schedule certainty and cost predictability. In some cases, manufacturers have shifted procurement timelines or restructured bills of materials to mitigate exposure to tariff volatility.

Beyond immediate cost impacts, tariffs have catalyzed secondary strategic adaptations: OEMs and systems integrators are emphasizing modular designs that allow higher proportions of locally sourced subsystems, while maintenance and spares inventories have been revisited to reduce lead-time risks. Regulatory documentation and qualification plans have been updated to reflect alternate suppliers and validated replacements, reinforcing the need for robust change-control processes. The net effect is a more resilient, though operationally complex, sourcing posture across water system lifecycles.

Uncovering nuanced segmentation dynamics across product type, end user, application, and manufacturing process that drive technical and commercial differentiation in water systems

Segmentation analysis reveals distinct technology, user, application, and process niches that shape product selection, validation complexity, and lifecycle costs. Based on product type, the market is studied across Purified Water, Sterile Water For Injection, Water For Hemodialysis, and Water For Injection, where Purified Water is further examined across Deionization, Distillation, Reverse Osmosis, and Ultrafiltration; Distillation itself is analyzed through Batch Distillation and Continuous Distillation variations, while Reverse Osmosis is considered in Hollow Fiber and Spiral Wound configurations, and Water For Injection is further differentiated between Distillation and Membrane Technology with Membrane Technology explored via Ultrafiltration.

From an end-user perspective, the market segmentation recognizes Contract Research Organizations, Hospital & Clinics, and Pharmaceutical Manufacturing, with the latter further dissected into Biotechnology Firms, Generic Pharma, and Large Pharma to reflect divergent validation stringency, volume throughput, and capital tolerance. Application-driven segmentation spans Equipment Cleaning, Laboratory Use, Parenteral Solutions, and Sterile Packaging, with Parenteral Solutions subdivided into Intravenous Solutions and Irrigation Solutions and Intravenous Solutions further separated into Large Volume Solutions and Small Volume Solutions, underscoring distinct purity and endotoxin control requirements. Manufacturing process segmentation mirrors product-level differentiation through Deionization, Distillation, Reverse Osmosis, and Ultrafiltration, while granular process variants such as Batch versus Continuous Distillation and High Pressure versus Low Pressure Reverse Osmosis indicate different engineering trade-offs for energy, footprint, and redundancy. These layered segmentation lenses illuminate how choices in one domain-such as opting for ultrafiltration versus distillation for Water For Injection-cascade into validation protocols, operational staffing, and maintenance frequencies across use cases.

Regional strategic distinctions and operational priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption and deployment of pharmaceutical water solutions

Regional dynamics require a differentiated approach to deployment, compliance, and supplier engagement. The Americas exhibit concentrated investment in modernization and digital monitoring for installed assets, where regulatory expectations and large-scale biologics manufacturing hubs push toward rigorous validation frameworks and high uptime standards. Investment trends in this region often prioritize integration of remote monitoring and predictive maintenance to protect continuous manufacturing lines and high-value drug production.

Europe, Middle East & Africa present a heterogeneous landscape where mature regulatory regimes coexist with emerging markets that emphasize scalable, cost-effective solutions. Here, legacy distillation systems remain prevalent in certain markets while advanced membrane adoption grows in regions prioritizing sustainability and footprint reduction. Asia-Pacific features rapid expansion of manufacturing capacity and a pronounced appetite for modular, scalable systems that support contract manufacturing and regional biotech growth, with localized manufacturing and supplier networks evolving to meet demand while also navigating regional regulatory harmonization efforts.

Competitive landscape analysis highlighting how product integration, service excellence, and digital enablement separate leading water systems providers from niche and emerging players

Key company dynamics point to a competitive environment shaped by product breadth, regulatory expertise, service networks, and engineering capabilities. Leading system providers differentiate themselves through integrated solutions that combine water generation, distribution, monitoring, and lifecycle support, enabling clients to accelerate validation and reduce total cost of ownership. Companies with strong global service footprints and regional technical teams are better positioned to support multinational customers through harmonized qualification documentation and rapid field response.

Innovative firms are investing in digital platforms that unify equipment telemetry, electronic batch records, and preventive maintenance scheduling, thereby creating recurring service revenue opportunities. Partnerships between equipment specialists and validation consultancies are also becoming more common as end users seek turnkey delivery of water systems that meet stringent GMP expectations. New entrants and niche players focus on specialized membrane approaches, energy-efficient distillation variants, or compact systems tailored for small-scale clinical manufacturing, intensifying competition while expanding choice for facility designers and quality teams.

Actionable pathways for manufacturers and providers to strengthen compliance, resilience, and cost control while accelerating validation and operational uptime in water systems

Industry leaders should prioritize a sequence of strategic actions that balance compliance, resilience, and cost efficiency to navigate the evolving landscape. First, adopt modular system architectures and validated alternate sourcing strategies to reduce vulnerability to supply chain disruptions and tariff-driven cost pressures while maintaining validation continuity. Second, invest in automated monitoring, data integrity frameworks, and predictive maintenance programs to enhance uptime and satisfy lifecycle quality expectations without imposing excessive manual oversight.

Third, align procurement and engineering decisions with application-specific purity requirements, recognizing that solutions optimized for equipment cleaning or laboratory use differ materially from those required for parenteral or Water For Injection applications. Fourth, cultivate deeper collaborations with validated service partners and regional technical teams to compress response times and streamline change-control processes. By sequencing these actions and embedding them into capital planning and quality roadmaps, organizations can improve resilience, manage operating cost, and accelerate time to productive operation.

Robust mixed-method research approach combining practitioner interviews, standards analysis, and data triangulation to validate insights on pharmaceutical water systems

The research methodology applies a multi-layered approach combining primary engagement with industry practitioners and secondary compilation of technical standards, regulatory guidance, and peer-reviewed literature. Primary inputs include structured interviews with process engineers, quality assurance leads, procurement managers, and external validation experts, complemented by site-level observations of water generation and distribution systems to understand real-world operational constraints. Secondary research leverages regulatory documents, standards bodies' guidance, technical white papers, and published case studies to contextualize technological choices and compliance interpretations.

Data triangulation is achieved by cross-referencing interview findings with documented validation records and system performance metrics where available, and by validating key assertions through follow-up consultations with independent experts. The methodology emphasizes transparency around assumptions and limitation statements, and it applies conservative interpretation of qualitative inputs to reduce bias. Where applicable, methodological steps to ensure reproducibility include audit trails of interview protocols, documented criteria for source selection, and version control for any analytical models used in synthesizing findings.

Synthesis of strategic and operational imperatives highlighting how technical choices and organizational alignment define successful pharmaceutical water system programs

In conclusion, pharmaceutical grade water represents both a technical backbone and a strategic lever for manufacturers and clinical operators aiming to meet rising quality expectations and operational demands. Technology choices-from deionization and reverse osmosis configurations to distillation architectures and ultrafiltration membranes-directly influence validation complexity, maintenance regimes, and energy profiles, while end-user distinctions shape acceptable redundancy, documentation, and service needs.

Moving forward requires a coordinated approach that blends modern monitoring and automation with resilient sourcing strategies and application-specific engineering. Organizations that proactively align capital investment, quality systems, and supplier strategies will be better positioned to manage regulatory scrutiny, reduce downtime risk, and support the increasingly sophisticated production and clinical paradigms that define contemporary pharmaceutical operations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Grade Water Market, by Product Type

  • 8.1. Purified Water
    • 8.1.1. Deionization
    • 8.1.2. Distillation
      • 8.1.2.1. Batch Distillation
      • 8.1.2.2. Continuous Distillation
    • 8.1.3. Reverse Osmosis
      • 8.1.3.1. Hollow Fiber
      • 8.1.3.2. Spiral Wound
    • 8.1.4. Ultrafiltration
  • 8.2. Sterile Water For Injection
  • 8.3. Water For Hemodialysis
  • 8.4. Water For Injection
    • 8.4.1. Distillation
    • 8.4.2. Membrane Technology

9. Pharmaceutical Grade Water Market, by Manufacturing Process

  • 9.1. Deionization
  • 9.2. Distillation
    • 9.2.1. Batch Distillation
    • 9.2.2. Continuous Distillation
  • 9.3. Reverse Osmosis
    • 9.3.1. High Pressure
    • 9.3.2. Low Pressure
  • 9.4. Ultrafiltration

10. Pharmaceutical Grade Water Market, by End User

  • 10.1. Contract Research Organizations
  • 10.2. Hospital & Clinics
  • 10.3. Pharmaceutical Manufacturing
    • 10.3.1. Biotechnology Firms
    • 10.3.2. Generic Pharma
    • 10.3.3. Large Pharma

11. Pharmaceutical Grade Water Market, by Application

  • 11.1. Equipment Cleaning
  • 11.2. Laboratory Use
  • 11.3. Parenteral Solutions
    • 11.3.1. Intravenous Solutions
      • 11.3.1.1. Large Volume Solutions
      • 11.3.1.2. Small Volume Solutions
    • 11.3.2. Irrigation Solutions
  • 11.4. Sterile Packaging

12. Pharmaceutical Grade Water Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Pharmaceutical Grade Water Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Pharmaceutical Grade Water Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Pharmaceutical Grade Water Market

16. China Pharmaceutical Grade Water Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aquafilsep
  • 17.6. Aquatech International LLC
  • 17.7. AQUAVISTA
  • 17.8. Aqua-Chem, Inc.
  • 17.9. Asahi Kasei Corporation
  • 17.10. AWS Bio Pharma Technologies
  • 17.11. Biocell Pharma
  • 17.12. Biopuremax
  • 17.13. BWT Group
  • 17.14. CHIWATEC
  • 17.15. Ecolab Inc.
  • 17.16. Evoqua Water Technologies LLC
  • 17.17. Fabtech
  • 17.18. GEA Group Aktiengesellschaft
  • 17.19. GT Metal & Process
  • 17.20. Hydropure Systems
  • 17.21. Kurita Water Industries Ltd.
  • 17.22. LIVAM
  • 17.23. MECO
  • 17.24. Meissner Filtration Products, Inc.
  • 17.25. Paragon Pharmaceutical Equipment Co., Ltd.
  • 17.26. Parker Hannifin Corporation
  • 17.27. Pharmalab India
  • 17.28. Pure Aqua, Inc.
  • 17.29. SUEZ S.A.
  • 17.30. SUNCOMBE Ltd.
  • 17.31. Tianjin Chaotuo Medical Equipment
  • 17.32. Veolia Environnement S.A.
  • 17.33. WEMAC Pharma Systems
  • 17.34. Xylem Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL GRADE WATER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PHARMACEUTICAL GRADE WATER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PHARMACEUTICAL GRADE WATER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SPIRAL WOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SPIRAL WOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SPIRAL WOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE WATER FOR INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE WATER FOR INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE WATER FOR INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HIGH PRESSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HIGH PRESSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HIGH PRESSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LOW PRESSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LOW PRESSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LOW PRESSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOSPITAL & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOSPITAL & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GENERIC PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GENERIC PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY EQUIPMENT CLEANING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY EQUIPMENT CLEANING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY EQUIPMENT CLEANING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LABORATORY USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LABORATORY USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LABORATORY USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE VOLUME SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE VOLUME SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE VOLUME SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SMALL VOLUME SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SMALL VOLUME SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SMALL VOLUME SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY IRRIGATION SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY IRRIGATION SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY IRRIGATION SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 251. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 254. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 255. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 257. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 259. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 262. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 293. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 296. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 297. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 298. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 299. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 300. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 301. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLIO